Table 3.
Comorbidities of the COVID-19 patients.
| All |
Females |
Males |
||||
|---|---|---|---|---|---|---|
| n = 48 | % | n = 23 | % | n = 25 | % | |
| Comorbidities | ||||||
| Hypertension | 25 | 52.1 | 15 | 65.2 | 10 | 40.0 |
| T2DM | 14 | 29.2 | 8 | 34.8 | 6 | 24.0 |
| CHD | 6 | 12.5 | 3 | 13.0 | 3 | 12.0 |
| MCI | 4 | 8.3 | 1 | 4.3 | 3 | 12.0 |
| DVT | 3 | 6.3 | 1 | 4.3 | 2 | 8.0 |
| Allergies | 3 | 6.3 | 2 | 8.7 | 1 | 4.0 |
| Respiratory diseases* | 3 | 6.3 | 2 | 8.7 | 1 | 4.0 |
| Smokers | 3 | 4.2 | 2 | 8.7 | 1 | 4.0 |
| Insult | 2 | 4.2 | 1 | 4.3 | 1 | 4.0 |
| Cancer survivor | 1 | 2.1 | 1 | 4.3 | 0 | 0 |
| Other illnesses** | 6 | 7.3 | 1 | 4.3 | 5 | 20.0 |
T2DM: Type 2 diabetes mellitus; CHD: coronary heart disease;
MCI: mild cognitive impaired, DVT: deep venous thrombosis; *Asthma, COPD, **Gout, colonic ileus, lymphopenia, cirrhosis of the liver, sepsis.